Cancer Research Technology Limited (CRT) is a specialist commercialisation and development company, which aims to develop new discoveries in cancer research for the benefit of cancer patients.

Client comments: “Zyme Communications brought strategic guidance and sector expertise to the Ximbio launch project. Working to a very tight deadline, they successfully delivered a strategy plan and messaging document which informed all of our launch communications. The Zyme team quickly grasped the Ximbio concept and had a clear understanding of our target audiences. As a result, they were able to draft highly targeted communications and advise on key conferences and events. We enjoyed an excellent working relationship with Lorna and Katie, who also collaborated closely with our platform developers to deliver the project.”

Head of Ximbio.